New therapy aims to help psychosis patients quit cannabis
NCT ID NCT07245212
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a talking therapy called the Cannabis Clinic for Psychosis (CCP) to help people with first-episode psychosis reduce or stop cannabis use. The therapy includes motivational interviewing and cognitive behavioral therapy in weekly sessions over 12 weeks. Researchers will compare the therapy group to a waiting-list group receiving usual care, measuring changes in cannabis use. The goal is to see if this approach can improve outcomes and reduce relapses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
psychosocial intervention (motivational interviewing and cognitive behavioral therapy)
What this could lead to
If it works, this could provide an effective non-drug treatment to help people with psychosis cut down or quit cannabis, potentially reducing relapses and hospital stays.
What could go wrong
This is a small early-stage trial with only 80 participants, and it uses a waiting-list design. The therapy may not work for everyone, and results may not apply to broader populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Marina House
London, SE5 8RZ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••